Patient‐reported outcome measures (PROMs) to guide clinical care: recommendations and challenges

Author:

Agarwal Anupriya1ORCID,Pain Tilley2,Levesque Jean‐Frederic34,Girgis Afaf5,Hoffman Anna6,Karnon Jonathan7,King Madeleine T8,Shah Karan K1ORCID,Morton Rachael L1ORCID,

Affiliation:

1. NHMRC Clinical Trials Centre University of Sydney Sydney NSW

2. Townsville General Hospital Townsville QLD

3. Agency for Clinical Innovation NSW Health Sydney NSW

4. Centre for primary Health Care and Equity UNSW Sydney Sydney NSW

5. Ingham Institute for Applied Medical Research UNSW Sydney Sydney NSW

6. St George Hospital Sydney NSW

7. Flinders University Adelaide SA

8. University of Sydney Sydney NSW

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

General Medicine

Reference10 articles.

1. US Food and Drug Administration.Guidance for Industry: patient‐reported outcome measures: use in medical product development to support labeling claims; December 2009.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/patient‐reported‐outcome‐measures‐use‐medical‐product‐development‐support‐labeling‐claims(viewed Apr 2019).

2. A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)

3. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

4. Web-Based Patient-Reported Outcome Measures for Personalized Treatment and Care (PROMPT-Care): Multicenter Pragmatic Nonrandomized Trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3